Related Experiment Videos
Benign hereditary chorea--response to steroids
Developmental Medicine and Child Neurology
|December 1, 1985
Abstract:
A child with benign hereditary chorea is described, whose movement disorder remitted with systemic steroids. It is suggested that this effect, not previously described, relies on modulation of neurotransmitter function.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections.
Journal of neurology, neurosurgery, and psychiatry·2004
The impact of PET scanning on management of paediatric oncology patients.
European journal of nuclear medicine and molecular imaging·2004
Combined dorsal and ventral rhizotomy in non-ambulatory individuals with mixed spastic bilateral cerebral palsy: A prospective registry analysis.
Developmental medicine and child neurology·2026
Physical therapy interventions for children and adolescents with myelomeningocele: A systematic review.
Developmental medicine and child neurology·2026
Immersive virtual reality arm exercise, physical activity, and cardiometabolic health in cerebral palsy: A phase 1 trial.
Developmental medicine and child neurology·2026
Colony-stimulating factor 1 receptor-related disorder: Clinical variability of biallelic variants.
Developmental medicine and child neurology·2026
Perinatal, socioenvironmental, and neurological factors to predict motor delay in infants born preterm.
Developmental medicine and child neurology·2026
Rett syndrome in the therapeutic era: Rethinking diagnosis, boundaries, clinical outcomes, and financing.
Developmental medicine and child neurology·2026
Medical gases and hypertensive disorders of pregnancy: therapeutic mechanisms and research advances.
Medical gas research·2026
Treatment Injuries in Dupuytren Contracture: A Population-Based Study of Filed Compensation Claims.
Journal of hand surgery global online·2026
Histamine and the mechanisms of nausea and vomiting: Translating the uncertain pharmacology of cyclizine.
British journal of clinical pharmacology·2026
Kaempferol conjugated selenium nanoparticles mitigate kidney injury from rhabdomyolysis through antioxidant and anti-inflammatory actions via Nrf2/NF-κb pathway.
Naunyn-Schmiedeberg's archives of pharmacology·2026
[Illegal Drug: Metonitazene].
Fa yi xue za zhi·2026